Skip to main content

Table 2 Overview of bacterial-targeted MSNs delivery systems

From: Powering mesoporous silica nanoparticles into bioactive nanoplatforms for antibacterial therapies: strategies and challenges

Type of targeting

Targeting ligand

Bacterial

Type of device

Refs.

Electrostatic interaction

Quaternary ammonium polyethyleneimine (QPEI)

P. syringaepv. Lachrymans, Clavibacter michiganensis subsp. michiganensis

Ag@MSN-QPEI

[140]

Bionic recognition

Outer membrane vesicles (OMVs)

S. aureus、E. coli

Rif@MSN@OMV

[142]

Aptamers recognition

Trehalose

Mycobacteria

HOMSNs-Tre-INH

[143]

SA20hp

S. aureus

Aptamer-gate NP

[144]

Lactobacillus monocytogenes aptamer

L. monocytogenes

AptBACNPs

[145]

Antigen–antibody recognition

Anti-S. aureus antibody

S. aureus

Ab@S-HA@MMSNs

[146]

Staphylococcus aureus (S. aureus)-specific aptamer

S. aureus

RAHMSN@AGNR

[147]

Peptides recognition

Ovotransferrin-derived antibacterial peptide (OVTp12)

E. coli

MSNs@OVTp12@Gen

[93]

Peptide UBI29-41

S. aureus

MSN@D&U@V

[150]

Carbohydrates recognition

Gluconamide moieties

E. coli

glc-SiO2NPs

[151]

Trehalose

M. smegmatis

M-PFPA-Tre-INH

[152]